Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group

Publication date: Available online 24 April 2020Source: European Journal of Surgical OncologyAuthor(s): L. Vincent, C. Jankowski, L. Ouldamer, M. Ballester, S. Bendifallah, P.A. Bolze, C. Akladios, H. Costaz, V. Lavoué, G. Canlorbe, P. Collinet, C. Touboul, C. Huchon, A. Bricou, S. Dridi, M.M. Padéano, L. Bengrine, L. Arnould, C. Coutant, Groupe de Recherche FRANCOGYN
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research